SNRPF
Small nuclear ribonucleoprotein F
Also known as: RUXF_HUMAN, Sm-F
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P62306
- Gene
- SNRPF
- Ensembl
- ENSG00000139343
- Chromosome
- 12
- Canonical length
- 86 aa
- Protein class
- Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins
OverviewNCBI Gene
Enables RNA binding activity. Involved in spliceosomal snRNP assembly. Located in cytosol and nucleus. Part of several cellular components, including methylosome; nucleus; and pICln-Sm protein complex. Biomarker of nasopharynx carcinoma. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
86 residues, UniProt reviewed canonical sequence.
>P62306|SNRPF
1 MSLPLNPKPF LNGLTGKPVM VKLKWGMEYK GYLVSVDGYM NMQLANTEEY IDGALSGHLG
61 EVLIRCNNVL YIRGVEEEEE DGEMRELocalizationUniProt · AlphaFold · HPA
Whether an antibody against SNRPF can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.4
- Highest tissue expression
- 178 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 178 nTPM
- esophagus: 167 nTPM
- thymus: 160 nTPM
- liver: 138 nTPM
- tonsil: 135 nTPM
- lymph node: 128 nTPM
Single-cell type
- esophageal basal cells: 644 nCPM
- gastric progenitor cells: 610 nCPM
- extravillous trophoblasts: 522 nCPM
- migrating cytotrophoblasts: 484 nCPM
- esophageal suprabasal cells: 442 nCPM
- cytotrophoblasts: 420 nCPM
Immune cell
- myeloid DC: 217 nTPM
- plasmacytoid DC: 211 nTPM
- memory B-cell: 178 nTPM
- naive CD4 T-cell: 178 nTPM
- memory CD4 T-cell: 167 nTPM
- MAIT T-cell: 163 nTPM
Brain region
- hypothalamus: 35 nTPM
- midbrain: 32 nTPM
- cerebellum: 32 nTPM
- pons: 29 nTPM
- cerebral cortex: 28 nTPM
- medulla oblongata: 28 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.57
- gnomAD pLI
- 0.79
- gnomAD missense Z
- 1.88
- DepMap mean gene effect
- -2.85
- DepMap dependency class
- pan
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- 7-methylguanosine cap hypermethylation
- mRNA splicing, via spliceosome
- RNA splicing
- spliceosomal snRNP assembly
- U2-type prespliceosome assembly
Molecular functions
Cellular components
- catalytic step 2 spliceosome
- cytosol
- methylosome
- nucleoplasm
- nucleus
- pICln-Sm protein complex
- small nuclear ribonucleoprotein complex
- SMN-Sm protein complex
- spliceosomal complex
- U1 snRNP
- U12-type spliceosomal complex
- U2 snRNP
- U2-type catalytic step 2 spliceosome
- U2-type precatalytic spliceosome
- U2-type spliceosomal complex
- U4 snRNP
- U4/U6 x U5 tri-snRNP complex
- U5 snRNP
- U7 snRNP
Protein domainsUniProt · Pfam · InterPro
- Sm domain, eukaryotic/archaea-type
- LSM domain superfamily
- Sm-like protein Lsm6/SmF
- Sm domain
- LSM domain
- Small nuclear ribonucleoprotein F
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of SNRPF in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SNRPF as an antibody target. Whether an autoantibody or antibody against SNRPF could matter depends on whether native SNRPF is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SNRPF is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label SNRPF as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...